Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apatinib for Advanced Soft Tissue Sarcoma Patients After Failure of Traditional Therapy: an One-armed, Phase 2, Open-label, Multicenter Prospective Trial

NCT03104335 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03104335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03104335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apatinib for Advanced Soft Tissue Sarcoma Patients After Failure of Traditional Therapy: an One-armed, Phase 2, Open-label, Multicenter Prospective Trial
Lead sponsor
Peking University People's Hospital
Phase
Phase 2
Overall status
Withdrawn
Start date
April 1, 2017
Completion date
March 1, 2020
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, soft tissue sarcoma adult